Imvamune® vaccine is approved in Canada for protection against smallpox, monkeypox, and other orthopoxvirus-related illnesses.

Booster doses are currently offered-4th dose to older adults and 5th dose for immunocompromised ones as COVID-19 case counts are rising.

Health authorities are investigating confirmed monkeypox cases in Canada as part of an unprecedented monkeypox virus outbreak.